Please Wait...

Imaging Modalities

Medical and Diagnostic Imaging Modalities

Bioclinica has extensive experience with medical imaging and diagnostic imaging modalities for clinical trials.

CT

  • Angiography (CTA)
  • Lung Density/Volume
  • Quantitative Computed Tomography (QCT)

DXA

  • Bone Mineral Density (BMD)
  • Body Composition
  • Hip Structural Analysis (HSA)

MRI

  • Angiography (MRA)
  • Body and Neuro
  • Cardiac MRI
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI)

Nuclear Medicine

  • Planar
  • Multi-Gated Acquisition Scan (MUGA)
  • Single Photon Emission Computed Tomography (SPECT)
  • Whole Body
  • PET
  • PET/CT

OCT

  • Retinal thickness and volume
  • Retinal Nerve Fiber layer (RNFL) thickness
  • Macular holes and puckers

Ultrasound

  • Abdominal/small parts Ultrasound
  • Echocardiography
  • FMD (flow mediated dilation)
  • Duplex
  • Duplex Doppler
  • CEUS (Contrast Enhanced Ultrasound)
  • B-Mode and M-Mode

X-Ray

  • General
  • Angiography
  • Mammography

Want to learn more about how Bioclinica’s medical and diagnostic imaging modalities solutions can benefit your clinical studies? Request a demo today!

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

https://t.co/UZQTot9ovJ
bioclinica (18 hours ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (18 hours ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (18 hours ago)
RT @eClinical_Jen: Content from the FDA Webinar on Study Data Technical Conformance Guidelines is here: https://t.co/14eepSOR7b #ITTX17
bioclinica (18 hours ago)
RT @CenterWatch: .@US_FDA approves first #digital pill with sensor to track #patients adherence, https://t.co/XaEctKIFRx
bioclinica (18 hours ago)
RT @RAPSorg: Could you use a mid-week laugh? Many #regulatory pros will appreciate this one, courtesy of @CharlesTam https://t.co/8WxeftiCPv
bioclinica (18 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices